Bayer may end its M&A hiatus with big-bang deal in lifesciences

Bayer may end its M&A hiatus with big-bang deal in lifesciences

Bayer | Photo: Reuters

21 December, 2015

Allergan Bayer Bernstein Research Boehringer Ingelheim Covestro Dow Chemical Dupont Eli Lilly Exane BNP Paribas GlaxoSmithKline Merck & Co Novartis Pfizer Reckitt Benckiser Sanofi Syngenta Werner Baumann Zoetis

Printed by Unregistered user on Sat, 06 Dec 2025 06:53:03 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from World

Netflix to buy Warner Bros Discovery’s studios, streaming unit for $72b

SoftBank in talks to buy digital infra firm DigitalBridge: report